Rentokil Initial stock hits fresh 12-month low as Fitch affirms BBB rating

Rentokil Initial stock (ISIN GB00B082RF11) extended its recent weakness on September 17, 2026, with the London-listed shares touching a new 12-month low of 322.70 GBX during mid-day trading before last changing hands at 328.00 GBX, compared with a previous close of 328.30 GBX.

Stock under pressure near 52-week low

According to MarketBeat on September 17, 2026, Rentokil Initial plc shares on the London Stock Exchange fell to an intraday low of 322.70 GBX and last traded at 328.00 GBX, slightly below the prior close of 328.30 GBX.

The fresh low comes after a period of volatility. A separate price snapshot from the London Stock Exchange shows Rentokil Initial trading at 370.90 GBX with a daily decline of 1.46 percent versus a previous close of 376.40 GBX, highlighting how the stock has moved within a broad intraday range in recent sessions and remains close to its lower trading band over the past year.

Fitch affirms BBB rating as cash generation stays modest

The market weakness stands in contrast to a stable credit assessment. As Fitch Ratings reported on September 16, 2026, the agency affirmed Rentokil Initial’s long-term issuer default rating at BBB with a Stable Outlook, citing the company’s established market position and committed financial policy.

Fitch highlighted that North American pest control, excluding business services, accounted for 58 percent of adjusted operating profit in the first half of 2026, underlining the region’s importance for the group’s earnings profile.

Within that segment, revenue growth in North American pest control improved to 3.2 percent year-on-year in the first half of 2026, compared with 3.0 percent in the second half of 2025 and 1.2 percent in the first half of 2025, showing a gradual acceleration over three consecutive reporting periods.

The adjusted operating profit margin in North American pest control rose to 19.7 percent in the first half of 2026, up from 18.5 percent in the first half of 2025, a gain of 1.2 percentage points that reflects ongoing cost synergies and improved route density according to Fitch Ratings.

The rating agency nevertheless pointed out that free cash flow margins remain modest for the BBB category. Fitch now forecasts cash flow from operations less capital expenditure and debt repayments at 8 percent to 10 percent of sales in 2026 and 2027, with free cash flow margins expected at 1 percent to 2 percent across 2026 to 2028, indicating limited headroom for rapid deleveraging.

At the end of June 2026, Rentokil Initial held about USD 2.3 billion of cash, or USD 1.4 billion net of overdraft facilities, which provides liquidity but also reflects the company’s need to balance investment, integration of past acquisitions and shareholder returns, according to Fitch Ratings.

First-half 2026 results show mixed picture

Recent fundamental data underline a combination of growth and execution challenges. As Investing.com reported in mid-September 2026, Rentokil Initial’s first-half 2026 revenue increased by 4.5 percent to USD 3.589 billion, compared with a market forecast of USD 3.661 billion, meaning the company undershot analyst expectations by USD 0.072 billion.

Operating profit for the same period rose by 6.6 percent to USD 556 million, demonstrating that profitability grew faster than revenue and suggesting a modest margin expansion at group level, according to Investing.com.

Free cash flow showed a stronger improvement, with a 12.8 percent increase in the first half of 2026 and a reported cash conversion rate of 96 percent, meaning nearly all reported profit translated into cash during the period, which is a positive signal for balance sheet resilience and dividend capacity.

However, the same report noted that Rentokil Initial retired its previously communicated 2027 North America 20 percent margin target, a move that signals a more cautious stance on what can be achieved in the region in the near term and has contributed to market concerns about growth and profitability trajectories in its largest market.

Investing.com also highlighted that revenue growth in international markets reached 5.0 percent in the first half of 2026, with organic growth in international pest control accelerating to 5.4 percent in the second quarter, underscoring that the company continues to expand outside North America even as it adjusts its strategic priorities.

Analyst sentiment weakened by downgrade and valuation gaps

Investor sentiment toward Rentokil Initial stock has been shaped by recent analyst actions. According to Investing.com, BNP Paribas Exane downgraded Rentokil Initial from Outperform to Neutral in connection with the first-half 2026 update, citing restructuring concerns and slowing growth in the core U.S. pest control business.

The downgrade reflects the view that previous integration and efficiency initiatives have not yet positioned Rentokil Initial for sustainable, high-margin growth in North America, making the region both a key earnings driver and a central risk factor for shareholders.

Despite this downgrade, broader consensus remains relatively constructive. As MarketBeat noted on September 17, 2026, Rentokil Initial stock carries an average analyst rating of Moderate Buy, with an average price target of 455.75 GBX.

Even taking the lower end of the price target range cited by Investing.com, which lies between USD 26.70 and USD 35.00 for the New York-traded American depositary receipt, the targets sit clearly above the recent ADR low of USD 21.99, suggesting that analysts still see upside from the current depressed levels.

The gap between the London share price, which recently traded near 328.00 GBX after touching a 12-month low of 322.70 GBX, and the average target of 455.75 GBX represents a potential upside of roughly one-third if the company can deliver on its operating and cash flow forecasts, although such upside is contingent on resolving growth issues in North America and maintaining credit metrics within Fitch’s rating sensitivities.

Dividend and upcoming Q3 2026 update

Dividend payments and upcoming reporting dates provide additional structure to the investment case. As summarized by a recent overview on MarketScreener, Rentokil Initial announced an interim dividend for the half-year ended June 30, 2026, payable on September 21, 2026, following the first-half 2026 results, continuing the company’s practice of returning cash to shareholders while balancing investment needs.

The same MarketScreener-based summary indicates that the next scheduled operating update, a trading overview for the third quarter of 2026, is planned for October 22, 2026, giving investors a specific date on which management is expected to provide further detail on the trajectory of North American pest control and the execution of cost synergies.

Rentokil Initial stock around its latest closing level

On the London Stock Exchange, Rentokil Initial stock trades under the ticker RTO. A recent LSE quote shows the shares at 370.90 GBX with a daily decline of 1.46 percent from a previous close of 376.40 GBX, on volume of 10,445,562 shares, in GBX terms as of mid-September 2026. For investors, the combination of a fresh 12-month low, modest but improving margins in key segments and a stable BBB credit rating frames Rentokil Initial as a stock where execution in North America and cash generation over the coming quarters will be decisive.

More news and analyses on Rentokil Initial stock